Skip to content

Upskilling physiotherapists in evidence-based assessment and management of patients with rheumatoid arthritis: a single-blind randomised controlled trial

A randomised controlled trial on the effectiveness of the Rheumatoid Arthritis for Physiotherapists eLearning package (RAP-eL) in improving the confidence, knowledge and skills of Australian registered physiotherapists in rheumatoid arthritis management

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000659707
Enrollment
128
Registered
2013-06-17
Start date
2013-07-25
Completion date
2013-07-25
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this research project is to evaluate the effectiveness of the resource, “Rheumatoid Arthritis for Physiotherapists – eLearning” (RAP-eL), in improving confidence and knowledge of best-practice physiotherapy management of rheumatoid arthritis. The evaluation of the RAP-eL resource aims to answer two research questions: 1. Is the RAP-eL resource effective in improving physiotherapists’ confidence and knowledge in the management of rheumatoid arthritis? 2. Are changes in confidence and knowledge retained over time?

Interventions

The Rheumatoid Arthritis for Physiotherapist eLearning package is a series of four web-based learning modules (disease and recognition; early stages; chronic stages and extra-articular features and co-morbid conditions) and two case studies. Each module consists of text content, videos of people with rheumatoid arthritis; practice points and clinical resources. The two case studies provide case histories and clinically related questions with answers. It is expected that each module and case

The Rheumatoid Arthritis for Physiotherapist eLearning package is a series of four web-based learning modules (disease and recognition; early stages; chronic stages and extra-articular features and co-morbid conditions) and two case studies. Each module consists of text content, videos of people with rheumatoid arthritis; practice points and clinical resources. The two case studies provide case histories and clinically related questions with answers. It is expected that each module and case study should take no more than 30 minutes to complete. So in total the whole package could be completed in three hours. During this study, physiotherapists will be give a period of four weeks in which to complete the modules and case studies. All learning modules will be made available at the one time so that the physiotherapist can work through it at his/her own pace. The total time of intervention and follow up for the intervention group is 12 weeks while for the control group it is 17 weeks. This is because after the randomised controlled trial the study will continue as a cohort study to the eight week follow up period for each group. Because the control group will get access to the intervention at the end of week 5, the four weeks intervention for them plus the 8 week follow up period finishes at 17 weeks.

Sponsors

Dr Andrew Briggs
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Australian-registered physiotherapists Proficiency in written and spoken English

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026